Robust Bayesian methods for monitoring clinical trials.
暂无分享,去创建一个
[1] W. Wong,et al. The calculation of posterior distributions by data augmentation , 1987 .
[2] J. Berger,et al. Ranges of posterior measures for priors with unimodal contaminations , 1989 .
[3] D. Spiegelhalter,et al. The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials , 1983 .
[4] Siva Sivaganesan,et al. Range of posterior measures for priors with arbitrary contaminations , 1988 .
[5] L. M. Berliner,et al. Robust Bayes and Empirical Bayes Analysis with $_\epsilon$-Contaminated Priors , 1986 .
[6] L L Miller,et al. Stopping a clinical trial very early because of toxicity: summarizing the evidence. , 1993, Controlled clinical trials.
[7] L. Tierney. Exploring Posterior Distributions Using Markov Chains , 1992 .
[8] D J Spiegelhalter,et al. Comparison of Bayesian with group sequential methods for monitoring clinical trials. , 1989, Controlled clinical trials.
[9] J Cornfield,et al. The Bayesian outlook and its application. , 1969, Biometrics.
[10] S. Emerson,et al. Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach. , 1995, Biometrics.
[11] M D Hughes,et al. Reporting Bayesian analyses of clinical trials. , 1993, Statistics in medicine.
[12] J. Berger. Robust Bayesian analysis : sensitivity to the prior , 1990 .
[13] D. Berry. Monitoring accumulating data in a clinical trial. , 1989, Biometrics.
[14] L. Wasserman,et al. Bayesian Inference with Specified Prior Marginals , 1991 .
[15] Ward Edwards,et al. Bayesian statistical inference for psychological research. , 1963 .
[16] Thomas A. Louis,et al. Graphical Elicitation of a Prior Distribution for a Clinical Trial , 1993 .
[17] Adrian F. M. Smith,et al. Sampling-Based Approaches to Calculating Marginal Densities , 1990 .
[18] J B Kadane,et al. Progress toward a more ethical method for clinical trials. , 1986, The Journal of medicine and philosophy.